
Cynthia A. Stuenkel, MD, NCMP

North American Menopause Society
Endocrinology
3 Answers7 Followers22 Helpful Answer Votes
Bio
A founding member of The North American Menopause Society (NAMS), Cynthia A. Stuenkel, MD, NCMP, is a clinical professor of medicine at the University of California, San Diego School of Medicine and an attending physician for the university’s Endocrinology and Metabolism Service.
Stuenkel’s interest in menopause was forged during her UCSD reproductive endocrinology fellowship. “While attending patient information sessions, I was struck by hearing the same story over and over from women whose symptoms were not understood and whose needs were not being met. As a fellow, I had the opportunity to learn more about gynecology and reproductive hormones than most internists. And as an internist, I brought knowledge about osteoporosis and cardiovascular disease to the table, topics less familiar to most gynecologists at the time. Working with women facing the challenges of menopause seemed a perfect fit for me.”
Stuenkel’s interest in menopause was forged during her UCSD reproductive endocrinology fellowship. “While attending patient information sessions, I was struck by hearing the same story over and over from women whose symptoms were not understood and whose needs were not being met. As a fellow, I had the opportunity to learn more about gynecology and reproductive hormones than most internists. And as an internist, I brought knowledge about osteoporosis and cardiovascular disease to the table, topics less familiar to most gynecologists at the time. Working with women facing the challenges of menopause seemed a perfect fit for me.”
Credentials
Organization Affiliations:
- North American Menopause Society
- American College of Obstetricians and Gynecologists
- University of California, San Diego, School of Medicine
My Answers
A.
Once you and your clinician have decided that it's time to stop, what's the best approach? The simple answer is that we don't know. Formal studies to...
A.
Only women who no longer have a uterus should consider using estrogen-alone therapy (ET). For women with a uterus, the option they might consider is...
A.
The main concern with prolonged HT is an increased risk of breast cancer. The risk seems to be greater in women taking combined therapy (estrogen...











